Cardiotonic agents in the management of chronic cardiac failure

Karl Weber, Virginia Andrews, Joseph S. Janicki

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Heart failure is a syndrome with distinct clinical signs and symptoms. The severity of cardiac failure and a deterioration in functional capacity can be determined by a progressive exercise test and by the noninvasive determination of maximum oxygen uptake. In patients with severe cardiac failure refractory to medical therapy, particularly those with cardiomyopathy or ischemic heart disease, survival is seriously compromised, resembling the most serious malignancy. Cardiotonic agents may be useful in improving the quality of life, provided that they are effective and are given sufficiently early in the course of the disease. Dobutamine given intravenously augments cardiac performance and improves renal function in patients with very advanced disease refractory to multiple diuretics; long-term survival, however, remains dismal. Amrinone appears to be a promising agent for the long-term treatment of chronic cardiac failure; the utility of pirbuterol, an oral catecholamine analog, remains to be determined.

Original languageEnglish (US)
Pages (from-to)639-649
Number of pages11
JournalAmerican Heart Journal
Volume103
Issue number4 PART 2
DOIs
StatePublished - Jan 1 1982
Externally publishedYes

Fingerprint

Cardiotonic Agents
Heart Failure
Amrinone
Dobutamine
Survival
Cardiomyopathies
Exercise Test
Diuretics
Signs and Symptoms
Catecholamines
Myocardial Ischemia
Quality of Life
Oxygen
Kidney
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiotonic agents in the management of chronic cardiac failure. / Weber, Karl; Andrews, Virginia; Janicki, Joseph S.

In: American Heart Journal, Vol. 103, No. 4 PART 2, 01.01.1982, p. 639-649.

Research output: Contribution to journalArticle

Weber, Karl ; Andrews, Virginia ; Janicki, Joseph S. / Cardiotonic agents in the management of chronic cardiac failure. In: American Heart Journal. 1982 ; Vol. 103, No. 4 PART 2. pp. 639-649.
@article{e1ebedf723154da4b1a5f7409dbc4430,
title = "Cardiotonic agents in the management of chronic cardiac failure",
abstract = "Heart failure is a syndrome with distinct clinical signs and symptoms. The severity of cardiac failure and a deterioration in functional capacity can be determined by a progressive exercise test and by the noninvasive determination of maximum oxygen uptake. In patients with severe cardiac failure refractory to medical therapy, particularly those with cardiomyopathy or ischemic heart disease, survival is seriously compromised, resembling the most serious malignancy. Cardiotonic agents may be useful in improving the quality of life, provided that they are effective and are given sufficiently early in the course of the disease. Dobutamine given intravenously augments cardiac performance and improves renal function in patients with very advanced disease refractory to multiple diuretics; long-term survival, however, remains dismal. Amrinone appears to be a promising agent for the long-term treatment of chronic cardiac failure; the utility of pirbuterol, an oral catecholamine analog, remains to be determined.",
author = "Karl Weber and Virginia Andrews and Janicki, {Joseph S.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/0002-8703(82)90469-0",
language = "English (US)",
volume = "103",
pages = "639--649",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4 PART 2",

}

TY - JOUR

T1 - Cardiotonic agents in the management of chronic cardiac failure

AU - Weber, Karl

AU - Andrews, Virginia

AU - Janicki, Joseph S.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Heart failure is a syndrome with distinct clinical signs and symptoms. The severity of cardiac failure and a deterioration in functional capacity can be determined by a progressive exercise test and by the noninvasive determination of maximum oxygen uptake. In patients with severe cardiac failure refractory to medical therapy, particularly those with cardiomyopathy or ischemic heart disease, survival is seriously compromised, resembling the most serious malignancy. Cardiotonic agents may be useful in improving the quality of life, provided that they are effective and are given sufficiently early in the course of the disease. Dobutamine given intravenously augments cardiac performance and improves renal function in patients with very advanced disease refractory to multiple diuretics; long-term survival, however, remains dismal. Amrinone appears to be a promising agent for the long-term treatment of chronic cardiac failure; the utility of pirbuterol, an oral catecholamine analog, remains to be determined.

AB - Heart failure is a syndrome with distinct clinical signs and symptoms. The severity of cardiac failure and a deterioration in functional capacity can be determined by a progressive exercise test and by the noninvasive determination of maximum oxygen uptake. In patients with severe cardiac failure refractory to medical therapy, particularly those with cardiomyopathy or ischemic heart disease, survival is seriously compromised, resembling the most serious malignancy. Cardiotonic agents may be useful in improving the quality of life, provided that they are effective and are given sufficiently early in the course of the disease. Dobutamine given intravenously augments cardiac performance and improves renal function in patients with very advanced disease refractory to multiple diuretics; long-term survival, however, remains dismal. Amrinone appears to be a promising agent for the long-term treatment of chronic cardiac failure; the utility of pirbuterol, an oral catecholamine analog, remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0020456390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020456390&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(82)90469-0

DO - 10.1016/0002-8703(82)90469-0

M3 - Article

VL - 103

SP - 639

EP - 649

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4 PART 2

ER -